FDA Inspection 1255311 — Andrzej Emeryk, M.D.
The FDA completed an inspection of Andrzej Emeryk, M.D. on November 18, 2024 in Lublin. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 18, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lublin (Poland)
Additional Details
Clinical Investigator (CI)